Cecile F. Conter

1 Place Professeur Joseph Renaut, 
Lyon, FR 
Clinical Trials:Currently Recruiting for 1 Trial
1 Place Professeur Joseph Renaut, 
Lyon, FR 

Overview

Cecile Conter practices practicing medicine in Lyon, France.

Her clinical expertise encompasses Febrile Neutropenia, Retinoblastoma, Ependymoma, and Gliomatosis Cerebri.

She is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 4 clinical trials.

Gender

Female

Locations

1 Place Professeur Joseph Renaut, Lyon, 69008, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018
Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018
Enrollment Status: Recruiting
Publish Date: November 28, 2025
Intervention Type: Drug, Device
Study Drugs: Melphalan or Melphalan + Topotecan, Etoposide, Carboplatin and Vincristine, Carboplatin, Intravitreal Melphalan Chemotherapy Injections
Study Phase: Phase 2/Phase 3
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Enrollment Status: Active_not_recruiting
Publish Date: January 07, 2026
Intervention Type: Procedure, Drug, Radiation, Other
Study Drugs: Etoposide, Vincristine, Carboplatin, Cyclophosphamide, Thiotepa
Study Phase: Phase 2
A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Enrollment Status: Active_not_recruiting
Publish Date: July 08, 2024
Intervention Type: Drug
Study Drugs: Cobimetinib, Atezolizumab
Study Phase: Phase 1/Phase 2
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Enrollment Status: Completed
Publish Date: November 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

9 Total Publications

Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.
Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.
Journal: European journal of pediatrics
Published: August 01, 2020

Frequently Asked Questions about Cecile F. Conter

Is Cecile F. Conter a top-rated expert for Febrile Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Cecile F. Conter is classified as an Experienced expert for Febrile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Cecile F. Conter participate in research or clinical trials?

Yes. Cecile F. Conter has published 9 articles and abstracts on conditions like Febrile Neutropenia. You can view a list of Cecile F. Conter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Conter's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile